Skip to main content

Compugen Announces Addition of Two Proteins to Pipeline

NEW YORK, June 7 (GenomeWeb News) - Compugen said today that it has recently added two novel therapeutic proteins, identified using the company's discovery engines, to its research pipeline.

 

According to the company, the proteins are CGEN M-3, a soluble kinase receptor with potential applications in cancer, and CGEN P-4, a peptide that may be useful in the areas of obesity and eating disorders.

 

The proteins, said Compugen, were initially predicted in-silico and are now being evaluated in the company's molecular biology labs.

 

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.